Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Trump and Kennedy pushed unproven leucovorin for autism, causing a 71% prescription surge; FDA later clarified it's only approved for a rare condition with no evidence for autism.

flag In 2025, President Trump and HHS Secretary Robert F. Kennedy Jr. promoted leucovorin as a potential autism treatment, triggering a 71% rise in prescriptions for children. flag The FDA later clarified the drug is only approved for cerebral folate deficiency, a rare condition, and emphasized there is no scientific evidence supporting its use for autism. flag The reversal followed concerns over flawed studies and lack of large-scale trials, prompting warnings from medical experts about promoting unproven therapies. flag The episode raised questions about the influence of political figures on public health decisions and the importance of evidence-based medicine.

4 Articles